Loading…
Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate
The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a micropart...
Saved in:
Published in: | European journal of pharmaceutical sciences 2017-01, Vol.96, p.20-27 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3 |
container_end_page | 27 |
container_issue | |
container_start_page | 20 |
container_title | European journal of pharmaceutical sciences |
container_volume | 96 |
creator | Sironi, Daniel Rosenberg, Jörg Bauer-Brandl, Annette Brandl, Martin |
description | The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time.
Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present.
Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations.
[Display omitted] |
doi_str_mv | 10.1016/j.ejps.2016.09.001 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835379618</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0928098716303529</els_id><sourcerecordid>1835379618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMouq7-AQ_So5d2p2m3acCL-A2CF70a0mYiWdqkJq2w_97UVY-eZg7P-zLzEHKWQ5ZDXq02GW6GkNG4Z8AzgHyPLPKa8RQYhX2yAE7rFHjNjshxCBsAqGoGh-SIsjVneVksyNvN1sretIkyIbhuGo2z6WpA36P83kcMo7HvidOJldalibQqiQHvBulH03aYaOf7qfvGw8xptE6bxssRT8iBll3A05-5JK93ty_XD-nT8_3j9dVT2hbrakwRkCle8Ro0Raa1KgG1ZrJpSoVrZAwoAi8kLVmjaM1QFoy2VckKyrVqZLEkF7vewbuPKZ4sehNa7Dpp0U1B5HWxLhiv4lwSukPjCyF41GLwppd-K3IQs1exEbNXMXsVwEX0GkPnP_1T06P6i_yKjMDlDsD45adBL0Jr0LaojMd2FMqZ__q_AFayi9c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835379618</pqid></control><display><type>article</type><title>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</title><source>ScienceDirect Journals</source><creator>Sironi, Daniel ; Rosenberg, Jörg ; Bauer-Brandl, Annette ; Brandl, Martin</creator><creatorcontrib>Sironi, Daniel ; Rosenberg, Jörg ; Bauer-Brandl, Annette ; Brandl, Martin</creatorcontrib><description>The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time.
Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present.
Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations.
[Display omitted]</description><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><identifier>DOI: 10.1016/j.ejps.2016.09.001</identifier><identifier>PMID: 27597143</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Diffusion ; Dissolution/permeation ; Drug Compounding ; Drug Liberation ; Dynamic ; Enabling formulation ; Fenofibrate - chemistry ; Hypolipidemic Agents - chemistry ; Intestinal Secretions - chemistry ; Microparticle ; Nanoparticle ; Nanoparticles - chemistry ; Particle Size ; Permeability ; Solubility ; Solubilization ; Supersaturation</subject><ispartof>European journal of pharmaceutical sciences, 2017-01, Vol.96, p.20-27</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</citedby><cites>FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</cites><orcidid>0000-0001-9598-5508 ; 0000-0003-3561-5016</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27597143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sironi, Daniel</creatorcontrib><creatorcontrib>Rosenberg, Jörg</creatorcontrib><creatorcontrib>Bauer-Brandl, Annette</creatorcontrib><creatorcontrib>Brandl, Martin</creatorcontrib><title>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</title><title>European journal of pharmaceutical sciences</title><addtitle>Eur J Pharm Sci</addtitle><description>The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time.
Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present.
Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations.
[Display omitted]</description><subject>Diffusion</subject><subject>Dissolution/permeation</subject><subject>Drug Compounding</subject><subject>Drug Liberation</subject><subject>Dynamic</subject><subject>Enabling formulation</subject><subject>Fenofibrate - chemistry</subject><subject>Hypolipidemic Agents - chemistry</subject><subject>Intestinal Secretions - chemistry</subject><subject>Microparticle</subject><subject>Nanoparticle</subject><subject>Nanoparticles - chemistry</subject><subject>Particle Size</subject><subject>Permeability</subject><subject>Solubility</subject><subject>Solubilization</subject><subject>Supersaturation</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE1LxDAQhoMouq7-AQ_So5d2p2m3acCL-A2CF70a0mYiWdqkJq2w_97UVY-eZg7P-zLzEHKWQ5ZDXq02GW6GkNG4Z8AzgHyPLPKa8RQYhX2yAE7rFHjNjshxCBsAqGoGh-SIsjVneVksyNvN1sretIkyIbhuGo2z6WpA36P83kcMo7HvidOJldalibQqiQHvBulH03aYaOf7qfvGw8xptE6bxssRT8iBll3A05-5JK93ty_XD-nT8_3j9dVT2hbrakwRkCle8Ro0Raa1KgG1ZrJpSoVrZAwoAi8kLVmjaM1QFoy2VckKyrVqZLEkF7vewbuPKZ4sehNa7Dpp0U1B5HWxLhiv4lwSukPjCyF41GLwppd-K3IQs1exEbNXMXsVwEX0GkPnP_1T06P6i_yKjMDlDsD45adBL0Jr0LaojMd2FMqZ__q_AFayi9c</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Sironi, Daniel</creator><creator>Rosenberg, Jörg</creator><creator>Bauer-Brandl, Annette</creator><creator>Brandl, Martin</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9598-5508</orcidid><orcidid>https://orcid.org/0000-0003-3561-5016</orcidid></search><sort><creationdate>20170101</creationdate><title>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</title><author>Sironi, Daniel ; Rosenberg, Jörg ; Bauer-Brandl, Annette ; Brandl, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Diffusion</topic><topic>Dissolution/permeation</topic><topic>Drug Compounding</topic><topic>Drug Liberation</topic><topic>Dynamic</topic><topic>Enabling formulation</topic><topic>Fenofibrate - chemistry</topic><topic>Hypolipidemic Agents - chemistry</topic><topic>Intestinal Secretions - chemistry</topic><topic>Microparticle</topic><topic>Nanoparticle</topic><topic>Nanoparticles - chemistry</topic><topic>Particle Size</topic><topic>Permeability</topic><topic>Solubility</topic><topic>Solubilization</topic><topic>Supersaturation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sironi, Daniel</creatorcontrib><creatorcontrib>Rosenberg, Jörg</creatorcontrib><creatorcontrib>Bauer-Brandl, Annette</creatorcontrib><creatorcontrib>Brandl, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sironi, Daniel</au><au>Rosenberg, Jörg</au><au>Bauer-Brandl, Annette</au><au>Brandl, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><addtitle>Eur J Pharm Sci</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>96</volume><spage>20</spage><epage>27</epage><pages>20-27</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><abstract>The aim of the current study was to evaluate a dynamic dissolution-/permeation-system for prediction of gastrointestinal and absorption-behavior of two commercial fenofibrate formulations. To this end, both dissolution and barrier-flux were followed simultaneously for fenofibrate powder, a microparticle formulation (Lipidil® 200mg) and a nanoparticle formulation (LIPIDIL 145 ONE®) using a pair of side-by side diffusion cells separated by a cellulose hydrate membrane. Under such dynamic conditions, transient supersaturation arising from the nanoparticle formulation could be demonstrated for the first time.
Furthermore, the dissolution-/permeation-system introduced here allowed for in-depth mechanistic insights: Biomimetic media, despite enhancing the apparent solubility of fenofibrate via micellar solubilization, did not increase permeation rate, irrespective whether the micro-/ or nanoparticle-formulation was tested. Nondissolved nano-/microparticles served as a reservoir helping to maintain high levels of molecularly dissolved drug, which in turn caused high and constant permeation rates. The micelle-bound drug may also serve as a drug-reservoir, yet of subordinate importance as long as there are nano-/microparticles present.
Despite the limitations of the current experimental set-up, combined dissolution-/permeation-testing appears a valuable new tool to promote mechanistic understanding during formulation development. Last but not least, the in vitro dissolution and permeation behavior revealed here was in good qualitative agreement with human duodenal and plasma values reported in literature for the same formulations.
[Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>27597143</pmid><doi>10.1016/j.ejps.2016.09.001</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-9598-5508</orcidid><orcidid>https://orcid.org/0000-0003-3561-5016</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0928-0987 |
ispartof | European journal of pharmaceutical sciences, 2017-01, Vol.96, p.20-27 |
issn | 0928-0987 1879-0720 |
language | eng |
recordid | cdi_proquest_miscellaneous_1835379618 |
source | ScienceDirect Journals |
subjects | Diffusion Dissolution/permeation Drug Compounding Drug Liberation Dynamic Enabling formulation Fenofibrate - chemistry Hypolipidemic Agents - chemistry Intestinal Secretions - chemistry Microparticle Nanoparticle Nanoparticles - chemistry Particle Size Permeability Solubility Solubilization Supersaturation |
title | Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dynamic%20dissolution-/permeation-testing%20of%20nano-%20and%20microparticle%20formulations%20of%20fenofibrate&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=Sironi,%20Daniel&rft.date=2017-01-01&rft.volume=96&rft.spage=20&rft.epage=27&rft.pages=20-27&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/10.1016/j.ejps.2016.09.001&rft_dat=%3Cproquest_cross%3E1835379618%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-e0e7d96980f2e7ffd40eff7abb4de5e7702e093a247bd287ea372c647329fdba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835379618&rft_id=info:pmid/27597143&rfr_iscdi=true |